Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × GRN163L peptide × Clear all

NCT05583552 2026-05-12

IMpress

Phase 2 Active not recruiting

46 enrolled 21 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute